Management Team

Christopher Springate, PhD, RPh
President and Chief Executive Officer

President and Chief Executive Officer and Director, Dr. Springate's corporate experience includes financing, intellectual property and patent issues, coordinating research collaborations, participation in research projects, product development and regulatory issues. Dr. Springate is a co-inventor of several patent applications for the use of therapeutics against surgical adhesions. He has successfully negotiated collaborative research and license agreements.

Dr. Springate gained industrial research and development experience before founding ARC through his involvement in the development and manufacture of novel drug loaded devices and polymeric formulations at Angiotech Pharmaceuticals, Inc. Dr. Springate is a licensed Pharmacist and with a PhD (Pharm) in Pharmaceutics & Biopharmaceutics, has an extensive knowledge of drugs and drug loaded devices. As the former Chief Executive Officer of ARC Pharmaceuticals Inc., Dr. Springate raised initial seed capital and obtained industrial research grants.

Bruce Hay, CA
Chief Financial Officer

Mr. Hay is the founder of ARC Medical Devices Inc. in 2010 and currently serves as the Chief Financial Officer. He is a professional accountant with more than 25 years of experience in raising private financing. Previously, Mr. Hay has been instrumental in raising private equity financings for ARC Pharmaceuticals Inc. Mr. Hay co-founded ImmGenics Pharmaceuticals Inc. in 1993 and as past Chief Financial Officer raised ImmGenics' initial seed capital and subsequent funds. Mr. Hay assisted in the sale of ImmGenics in 2000 to Abgenix, Inc. for approximately CAD 120 million.  Mr. Hay was a director of QLT Phototherapeutics Inc. from 1984 to 1988 and was instrumental in raising their first seed capital. He was instrumental in raising funds for a number of other early stage companies and has served on the board of directors of a number of public companies. He received a BComm from UBC and  received his CA from the Institute of Chartered Accountants of British Columbia. He was a manager with Coopers & Lybrand, and a partner in Hay & Watson.

Alex Huynh, CA
Chief Operating Officer

Ms. Huynh is a professional accountant with five years experience in public practice. Prior to joining the Company, she was the Chief Operating Officer of ARC Pharmaceuticals Inc. being responsible for the day-to-day operations. She holds a B.Sc. from UBC and received her CA from the Institute of Chartered Accountants of British Columbia in 2007.